Simposi
Pharmacological Control Of Tumor Ne Crosis Factor (Tnf) In Immunomediated Inflammatory Diseases (Imid): The Value Of Adalimumab
26 ottobre 2017 / 14.00-15.00
| 169 |
Pharmacological modulation of TNF in IMID: quality and safety profile Corrado Blandizzi (Pisa) |
| 170 |
Adalimumab value in adult IMID Ennio Giulio Favalli (Milan) |
| 171 |
Adalimumab value in child IMID Anna Belloni Fortina (Padova) |